Immunome (IMNM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov18

Lake Street analyst maintains a Buy rating on Immunome with a price target of $22

14:02

Nov7

Immunome released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 6.941 M, actual EPS USD -1.6763

04:00

Immunome released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 0 (forecast USD 611.11K), actual EPS USD -0.6532 (forecast USD -0.5759)

04:00

Nov3

Amin Focuses on Healthcare Sector Stocks

19:02

Oct23

Immunome Inc. Unveils Preclinical Data of ADC Payload HC74 at Conference

16:00

Oct7

Charles Zhu Reiterates Buy Rating on Immunome

10:47

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -57.46 M, EPS -0.6532

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.015 M, Net Income -43.4 M, EPS -0.4987

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.926 M, Net Income -41.64 M, EPS -0.5243

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change